These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 18065810

  • 21. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S.
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [Abstract] [Full Text] [Related]

  • 22. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
    Keogh KA, Wylam ME, Stone JH, Specks U.
    Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
    [Abstract] [Full Text] [Related]

  • 23. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
    de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO, EUVAS (European Vasculitis Study Group).
    Ann Intern Med; 2009 May 19; 150(10):670-80. PubMed ID: 19451574
    [Abstract] [Full Text] [Related]

  • 24. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.
    Hiemstra TF, Walsh M, Mahr A, Savage CO, de Groot K, Harper L, Hauser T, Neumann I, Tesar V, Wissing KM, Pagnoux C, Schmitt W, Jayne DR, European Vasculitis Study Group (EUVAS).
    JAMA; 2010 Dec 01; 304(21):2381-8. PubMed ID: 21060104
    [Abstract] [Full Text] [Related]

  • 25. Effects of cyclophosphamide on the prognosis of Japanese patients with renal vasculitis associated with anti-neutrophil cytoplasmic antibody-positive microscopic polyangiitis.
    Iwabuchi M, Nakaya I, Tsuchiya Y, Shibagaki Y, Yamaguchi T, Fukuhara S, Oe Y, Sakuma T, Sato T, Taguma Y, Soma J.
    Clin Exp Nephrol; 2016 Oct 01; 20(5):712-719. PubMed ID: 26590052
    [Abstract] [Full Text] [Related]

  • 26. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.
    Hu W, Liu Z, Chen H, Tang Z, Wang Q, Shen K, Li L.
    Chin Med J (Engl); 2002 May 01; 115(5):705-9. PubMed ID: 12133539
    [Abstract] [Full Text] [Related]

  • 27. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
    Eriksson P.
    J Intern Med; 2005 Jun 01; 257(6):540-8. PubMed ID: 15910558
    [Abstract] [Full Text] [Related]

  • 28. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.
    Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH.
    Ann Intern Med; 2005 Nov 01; 143(9):621-31. PubMed ID: 16263884
    [Abstract] [Full Text] [Related]

  • 29. Mycophenolate mofetil in the treatment of ocular inflammation in ANCA-associated vasculitis.
    Yalçindağ FN, Amer R, Forrester JV.
    J Ocul Pharmacol Ther; 2008 Apr 01; 24(2):249-54. PubMed ID: 18321200
    [Abstract] [Full Text] [Related]

  • 30. Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement.
    Chen Y, Bao H, Liu Z, Zhang H, Zeng C, Liu Z, Hu W.
    J Nephrol; 2014 Apr 01; 27(2):159-64. PubMed ID: 24570072
    [Abstract] [Full Text] [Related]

  • 31. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
    Branten AJ, du Buf-Vereijken PW, Vervloet M, Wetzels JF.
    Am J Kidney Dis; 2007 Aug 01; 50(2):248-56. PubMed ID: 17660026
    [Abstract] [Full Text] [Related]

  • 32. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR.
    Arthritis Rheum; 2005 Aug 01; 52(8):2461-9. PubMed ID: 16052573
    [Abstract] [Full Text] [Related]

  • 33. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L, Shuai Z, Hu Z, Zhang M, Chen S.
    Zhonghua Nei Ke Za Zhi; 2015 Jun 01; 54(6):511-6. PubMed ID: 26359012
    [Abstract] [Full Text] [Related]

  • 34. Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis.
    Tse KC, Tang CS, Lio WI, Lam MF, Chan TM.
    Lupus; 2006 Jun 01; 15(6):371-9. PubMed ID: 16830884
    [Abstract] [Full Text] [Related]

  • 35. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children].
    Yi ZW, Wu XC, Xu H, Zhou LJ, Wu YB, Feng SP, Zhou JH, Yang Q, Zhu GH, Liu AM, Wei MJ, Yu L, Zeng ZF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct 01; 10(5):575-8. PubMed ID: 18947472
    [Abstract] [Full Text] [Related]

  • 36. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.
    Harper L, Morgan MD, Walsh M, Hoglund P, Westman K, Flossmann O, Tesar V, Vanhille P, de Groot K, Luqmani R, Flores-Suarez LF, Watts R, Pusey C, Bruchfeld A, Rasmussen N, Blockmans D, Savage CO, Jayne D, EUVAS investigators.
    Ann Rheum Dis; 2012 Jun 01; 71(6):955-60. PubMed ID: 22128076
    [Abstract] [Full Text] [Related]

  • 37. Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study.
    Li C, Zhou ML, Liang DD, Wang JJ, Yang J, Zeng CH, Liu ZH, Zhang HT.
    BMJ Open; 2017 Jul 28; 7(7):e015668. PubMed ID: 28756384
    [Abstract] [Full Text] [Related]

  • 38. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS, de Joode AA, DeSevaux RG, Broekroelofs J, Voskuyl AE, van Paassen P, Kallenberg CG, Tervaert JW, Stegeman CA.
    Nephrol Dial Transplant; 2016 Sep 28; 31(9):1453-9. PubMed ID: 27242368
    [Abstract] [Full Text] [Related]

  • 39. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM, Tse KC, Tang CS, Mok MY, Li FK, Hong Kong Nephrology Study Group.
    J Am Soc Nephrol; 2005 Apr 28; 16(4):1076-84. PubMed ID: 15728784
    [Abstract] [Full Text] [Related]

  • 40. Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy.
    Lv J, Zhang H, Cui Z, Su T, Zhang Y, Wang H.
    Nephrol Dial Transplant; 2008 Sep 28; 23(9):2868-72. PubMed ID: 18463325
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.